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Diarrheal illness remains 1 of the top 5 causes of death 
in low-income and middle-income countries, especially for 
children <5 years of age. Introduction of universal childhood 
vaccination against rotaviruses has greatly reduced the 
incidence and severity of illness in upper-income and lower-
income settings. For adults, norovirus is the leading cause 
of sporadic cases and outbreaks of diarrheal illness and is 
responsible for nearly 21 million episodes annually in the 
United States, of which 5.5 million are foodborne. Public 
health efforts to control and prevent norovirus illness have 
focused on rapid outbreak detection and source identifi cation 
and control of transmission in institutional settings.
Diarrheal illness remains 1 of the top 5 causes of death in lower-income and middle-income countries 
(1), especially for children <5 years of age. In the ≈40 
years since the initial detection of Norwalk virus (2) and 
rotavirus (3) by electron microscopy in stool samples of 
patients with gastroenteritis, there has been increased 
recognition of the role of enteric viruses as a major cause 
of diarrhea-associated illness and death in young children 
and adults. Unfortunately, standard improvements in water 
and sanitation that reduce the incidence of enterically 
transmitted bacteria do not appear to be equally effective for 
reducing the incidence of enterically transmitted viruses. 
Thus, other public health approaches have been pursued for 
the control and prevention of viral gastroenteritis.
For children <5 years of age, rotavirus is the leading 
cause of diarrhea-associated illness and death. Fortunately, 
safe and effective vaccines against rotavirus illness 
are now available in many countries. Introduction of 
universal childhood vaccination against rotaviruses greatly 
reduces the incidence and severity of illness in upper-and 
lower-income settings (4). As a result, the World Health 
Organization recommended in 2009 that rotavirus vaccines 
be included in all national immunization programs (5).
In adults, norovirus is now recognized as the leading 
cause of sporadic cases (6) and outbreaks of diarrheal 
illness and is responsible for ≈21 million episodes annually 
in the United States, of which 5.5 million are foodborne 
(7). Efforts to develop effective vaccines for norovirus have 
been hindered by lack of a cell culture system to propagate 
the virus, large genetic diversity of norovirus strains, and 
apparent lack of long-term immunity generated by natural 
infection. Recent work on characterizing the interaction 
between noroviruses and their putative cellular receptors, 
histo–blood group antigens, may provide insights for 
development of specifi c antiviral compounds (8).
Public health efforts to control and prevent norovirus 
illness have focused primarily on outbreak detection and 
control. The implementation of CaliciNet, as described by 
Vega et al. (9), provides a useful new public health tool 
for rapid identifi cation of norovirus outbreaks. Similar 
to the successful PulseNet network for molecular typing 
of foodborne bacteria (10) and NoroNet in Europe (11), 
CaliciNet will enable linking of cases with identical 
sequence fi ngerprints into clusters of illness that may 
have a common exposure. This linking will be particularly 
useful in cases of illness related to food products with low 
levels of contamination in which identifi cation of exposure 
to a common food source may be diffi cult by epidemiologic 
methods alone.
Because a large proportion of norovirus illness results 
from foodborne exposures, considerable effort has gone 
into development of methods for detecting and eliminating 
virus contamination from food items, particularly shellfi sh 
(12) and fresh produce (13). Additionally, because 
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outbreaks of norovirus illness often occur in institutional 
settings, efforts are under way to standardize effective 
methods for disinfection of contaminated surfaces (14).
Finally, several other viruses, including astrovirus, 
sapovirus, and as described by Drexler et al. (15), Aichi 
virus, are also responsible for diarrheal illness in children 
and adults. Although the incidence and severity of illness 
caused by these pathogens may not warrant immediate 
development of vaccines, work continues to document 
their relative contributions to diarrhea-associated illness 
and death. Thus, although there is optimism for universal 
vaccination to prevent illness and death from severe 
rotavirus diarrhea and for reduction of norovirus illness by 
rapid outbreak detection and source identifi cation, there 
are still many challenges remaining for the control and 
prevention of viral gastroenteritis.
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